search
Back to results

MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study

Primary Purpose

Insulin Resistance, Metabolic Syndrome X, Dyslipidemia

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Isocaloric diet high in MUFA or Mediterranean diet
Sponsored by
Wageningen University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Insulin Resistance focused on measuring MUFA, Mediterranean diet, Insulin resistance, metabolic syndrome X

Eligibility Criteria

40 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Waist circumference ≥ 94 cm for men or ≥ 80 cm for women
  • Age from 40 to 65 years at the time of randomisation
  • Written informed consent obtained

Exclusion Criteria:

  • Unable or unwilling to comply with study procedures.
  • The use of drugs for lowering serum cholesterol, serum triglycerides, blood pressure, or diabetes.
  • Unusual dietary patterns, including high alcohol intakes
  • Recent (< 4 weeks) or current participation in a study with any investigational drug or dietary intervention.
  • High concentrations of total cholesterol (>8 mmol/L).
  • Diabetes mellitus.
  • Being pregnant or giving breastfeeding.

Sites / Locations

  • Hospital Gelderse Vallei
  • Wageningen University, Division of Human Nutrition

Outcomes

Primary Outcome Measures

Fasting Insulin

Secondary Outcome Measures

Systolic/ diastolic blood pressure
plasma glucose
serum HDL-cholesterol
serum triglycerides
waist-hip circumference
serum total cholesterol
serum LDL-cholesterol
Blood sample will be stored for measuring markers of inflammation.
Additionally in half of the subjects insulin sensitivity will be measured by the euglycemic hyperinsulinemic clamp.
Molecular markers in fat and muscle biopsies

Full Information

First Posted
November 28, 2006
Last Updated
December 10, 2007
Sponsor
Wageningen University
Collaborators
Netherlands Heart Foundation, Unilever R&D
search

1. Study Identification

Unique Protocol Identification Number
NCT00405197
Brief Title
MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study
Official Title
Study on the Effect of Mono-Unsaturated Fatty Acids (MUFA) and the Mediterranean Diet on Hyperinsulinemia and Other Components of the Metabolic Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
December 2007
Overall Recruitment Status
Completed
Study Start Date
November 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
April 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Wageningen University
Collaborators
Netherlands Heart Foundation, Unilever R&D

4. Oversight

5. Study Description

Brief Summary
Background: During the 1990s, the prevalence of the metabolic syndrome in the Netherlands ranged from 3% in women of 20-39 yrs to at least 33% in men 55 yrs and older and it is expected to increasing. Prevention is therefore warranted. In this respect the amount and type of fat in the diet deserves attention. Recently, an intervention study reported that a diet high in mono-unsaturated fatty acids (MUFA) such as from olive oil, increased insulin sensitivity in healthy subjects. However, additional beneficial effects can be expected from the Mediterranean diet as a whole. Hypothesis: Replacing saturated fatty acids (SFA) by mono-unsaturated fatty acids (MUFA) will improve hyperinsulinemia and dyslipidemia, and a typical Mediterranean diet will even have more pronounced effects. Study objectives: To investigate the impact of the Mediterranean diet, and especially the intake of MUFA, on markers of the metabolic syndrome in high-risk subjects. Methods: The controlled dietary intervention will include 60 subjects aged 40-65 years with moderate abdominal obesity. After a run-in diet for 2 weeks they will be assigned randomly to receive one of the three diets for a period of 8 weeks. Measurements of serum insulin concentration and other parameters will be carried out at weeks 2 and 10. Expected results: Our study will provide information on the role of MUFA and the expected beneficial impact of other factors of the Mediterranean type of diet on the metabolic syndrome.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insulin Resistance, Metabolic Syndrome X, Dyslipidemia, Hypertension, Overweight
Keywords
MUFA, Mediterranean diet, Insulin resistance, metabolic syndrome X

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Single
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Isocaloric diet high in MUFA or Mediterranean diet
Primary Outcome Measure Information:
Title
Fasting Insulin
Secondary Outcome Measure Information:
Title
Systolic/ diastolic blood pressure
Title
plasma glucose
Title
serum HDL-cholesterol
Title
serum triglycerides
Title
waist-hip circumference
Title
serum total cholesterol
Title
serum LDL-cholesterol
Title
Blood sample will be stored for measuring markers of inflammation.
Title
Additionally in half of the subjects insulin sensitivity will be measured by the euglycemic hyperinsulinemic clamp.
Title
Molecular markers in fat and muscle biopsies

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Waist circumference ≥ 94 cm for men or ≥ 80 cm for women Age from 40 to 65 years at the time of randomisation Written informed consent obtained Exclusion Criteria: Unable or unwilling to comply with study procedures. The use of drugs for lowering serum cholesterol, serum triglycerides, blood pressure, or diabetes. Unusual dietary patterns, including high alcohol intakes Recent (< 4 weeks) or current participation in a study with any investigational drug or dietary intervention. High concentrations of total cholesterol (>8 mmol/L). Diabetes mellitus. Being pregnant or giving breastfeeding.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Edith JM Feskens, Dr.
Organizational Affiliation
Division of Human Nutrition, Wageningen University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jeanne HM de Vries, Dr.
Organizational Affiliation
Division of Human Nutrition, Wageningen University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lisette CP de Groot, Prof.
Organizational Affiliation
Division of Human Nutrition, Wageningen University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lydia A. Afman, Dr.
Organizational Affiliation
Division of Human Nutrition, Wageningen University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Michael R. Muller, Prof.
Organizational Affiliation
Division of Human Nutrition, Wageningen University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Gelderse Vallei
City
Ede
ZIP/Postal Code
6710 HN
Country
Netherlands
Facility Name
Wageningen University, Division of Human Nutrition
City
Wageningen
Country
Netherlands

12. IPD Sharing Statement

Citations:
PubMed Identifier
15383514
Citation
Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004 Sep 22;292(12):1440-6. doi: 10.1001/jama.292.12.1440.
Results Reference
background
PubMed Identifier
11317662
Citation
Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH; KANWU Study. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001 Mar;44(3):312-9. doi: 10.1007/s001250051620.
Results Reference
background
PubMed Identifier
15826300
Citation
Panagiotakos DB, Polychronopoulos E. The role of Mediterranean diet in the epidemiology of metabolic syndrome; converting epidemiology to clinical practice. Lipids Health Dis. 2005 Apr 12;4:7. doi: 10.1186/1476-511X-4-7.
Results Reference
background
PubMed Identifier
16532897
Citation
Serra-Majem L, Roman B, Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev. 2006 Feb;64(2 Pt 2):S27-47. doi: 10.1111/j.1753-4887.2006.tb00232.x.
Results Reference
background
PubMed Identifier
22623392
Citation
van Dijk SJ, Feskens EJ, Bos MB, de Groot LC, de Vries JH, Muller M, Afman LA. Consumption of a high monounsaturated fat diet reduces oxidative phosphorylation gene expression in peripheral blood mononuclear cells of abdominally overweight men and women. J Nutr. 2012 Jul;142(7):1219-25. doi: 10.3945/jn.111.155283. Epub 2012 May 23.
Results Reference
derived
PubMed Identifier
19828712
Citation
van Dijk SJ, Feskens EJ, Bos MB, Hoelen DW, Heijligenberg R, Bromhaar MG, de Groot LC, de Vries JH, Muller M, Afman LA. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr. 2009 Dec;90(6):1656-64. doi: 10.3945/ajcn.2009.27792. Epub 2009 Oct 14.
Results Reference
derived

Learn more about this trial

MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study

We'll reach out to this number within 24 hrs